Levothyroxine Use in Infants and Children with Congenital or Acquired Hypothyroidism

Contributing Editor: Marcia L. Buck, Pharm.D.; Editorial Board: Kristi N. Hofer, Pharm.D.; Michelle W. McCarthy, Pharm.D.


Pediatr Pharm. 2008;14(10) 

In This Article

Formulary Update

The following actions were taken by the Pharmacy and Therapeutics Committee at their meeting on 9/26/08:

1. Ivermectin (Stromectol®), a broad-spectrum antiparasitic, was added to the Inpatient and Outpatient Formularies.

2. Oxandrolone, an anabolic steroid used to prevent weight loss in burn patients, was added to the Inpatient Formulary.

3. Bendamustine (Treanda®) was added with restriction to patients with B cell malignancies.

4. Rasburicase (Elitek®) was added for the management of uric acid levels in patients with tumor lysis syndrome.

5. Metronidazole gel (MetroGel®), temsirolimus (Torisel®), and certolizumab pegol (Cimzia®) were added to the Outpatient Formulary.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: